Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Shingyoji

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Anticancer Research|July 15, 2009
VEGF in patients with non-small cell lung cancer during combination chemotherapy of carboplatin and paclitaxelMasato Shingyoji, Soichiro Ando, Hiroki Nishimura, et al.
Neuro-Oncology Practice|June 9, 2025
Risk factors for type I leptomeningeal metastasis derived from non-small cell lung cancer and the impact of treatment for brain metastases on its developmentToshihiko Iuchi, Masato Shingyoji, Satoko Mizuno, et al.
Japanese Journal of Clinical Oncology|October 7, 2025
Pathogenesis-based treatment strategies for brain metastases from non-small cell cancerToshihiko Iuchi, Masato Shingyoji, Hironori Ashinuma, et al.
The Annals of Thoracic Surgery|August 24, 2014
Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancerMasato Shingyoji, Takahiro Nakajima, Mitsuru Yoshino, et al.
Cancer Cell International|December 15, 2017
Augmented expression of cardiac ankyrin repeat protein is induced by pemetrexed and a possible marker for the pemetrexed resistance in mesothelioma cellsYiyang Qin, Ikuo Sekine, Mengmeng Fan, et al.
Internal Medicine (Tokyo, Japan)|April 29, 2010
Restaging by endobronchial ultrasound-guided transbronchial needle aspiration in patients with inoperable advanced lung cancerMasato Shingyoji, Takahiro Nakajima, Hiroki Nishimura, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 30, 2020
Combination of a p53-activating CP-31398 and an MDM2 or a FAK inhibitor produces growth suppressive effects in mesothelioma with wild-type p53 genotypeBoya Zhong, Masato Shingyoji, Michiko Hanazono, et al.
Respirology (Carlton, Vic.)|October 6, 2010
Comparison of 21-gauge and 22-gauge aspiration needle during endobronchial ultrasound-guided transbronchial needle aspirationTakahiro Nakajima, Kazuhiro Yasufuku, Ryo Takahashi, et al.
Japanese Journal of Clinical Oncology|November 2, 2002
A case of pulmonary adenocarcinoma accompanied by superior vena caval thrombosis in a patient with peutz-jeghers syndromeSatoshi Hirano, Yuichi Takiguchi, Hidetoshi Igari, et al.
BMC Cancer|May 4, 2017
Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathwaysKengo Shimazu, Yuji Tada, Takao Morinaga, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Anticancer Research|July 15, 2009
VEGF in patients with non-small cell lung cancer during combination chemotherapy of carboplatin and paclitaxelMasato Shingyoji, Soichiro Ando, Hiroki Nishimura, et al.
Neuro-Oncology Practice|June 9, 2025
Risk factors for type I leptomeningeal metastasis derived from non-small cell lung cancer and the impact of treatment for brain metastases on its developmentToshihiko Iuchi, Masato Shingyoji, Satoko Mizuno, et al.
Japanese Journal of Clinical Oncology|October 7, 2025
Pathogenesis-based treatment strategies for brain metastases from non-small cell cancerToshihiko Iuchi, Masato Shingyoji, Hironori Ashinuma, et al.
The Annals of Thoracic Surgery|August 24, 2014
Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancerMasato Shingyoji, Takahiro Nakajima, Mitsuru Yoshino, et al.
Cancer Cell International|December 15, 2017
Augmented expression of cardiac ankyrin repeat protein is induced by pemetrexed and a possible marker for the pemetrexed resistance in mesothelioma cellsYiyang Qin, Ikuo Sekine, Mengmeng Fan, et al.
Internal Medicine (Tokyo, Japan)|April 29, 2010
Restaging by endobronchial ultrasound-guided transbronchial needle aspiration in patients with inoperable advanced lung cancerMasato Shingyoji, Takahiro Nakajima, Hiroki Nishimura, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 30, 2020
Combination of a p53-activating CP-31398 and an MDM2 or a FAK inhibitor produces growth suppressive effects in mesothelioma with wild-type p53 genotypeBoya Zhong, Masato Shingyoji, Michiko Hanazono, et al.
Respirology (Carlton, Vic.)|October 6, 2010
Comparison of 21-gauge and 22-gauge aspiration needle during endobronchial ultrasound-guided transbronchial needle aspirationTakahiro Nakajima, Kazuhiro Yasufuku, Ryo Takahashi, et al.
Japanese Journal of Clinical Oncology|November 2, 2002
A case of pulmonary adenocarcinoma accompanied by superior vena caval thrombosis in a patient with peutz-jeghers syndromeSatoshi Hirano, Yuichi Takiguchi, Hidetoshi Igari, et al.
BMC Cancer|May 4, 2017
Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathwaysKengo Shimazu, Yuji Tada, Takao Morinaga, et al.
Pageof 5